Company Filing History:
Years Active: 2010-2013
Title: Sigrid Ruuls: Innovator in Monoclonal Antibody Research
Introduction
Sigrid Ruuls is a prominent inventor based in De Bilt, Netherlands. She has made significant contributions to the field of biotechnology, particularly in the development of human monoclonal antibodies.
Latest Patents
Sigrid Ruuls holds 2 patents related to her groundbreaking work. Her latest patents include isolated human monoclonal antibodies against CD20. These antibodies bind to and inhibit human CD20, and they are part of related antibody-based compositions and molecules. The human antibodies can be produced by a transfectoma or in a non-human transgenic animal, such as a transgenic mouse, which is capable of producing multiple isotypes of human monoclonal antibodies through V-D-J recombination and isotype switching. Additionally, her patents disclose pharmaceutical compositions comprising these human antibodies, as well as therapeutic and diagnostic methods for their use.
Career Highlights
Sigrid Ruuls has established herself as a key figure in the biotechnology sector. She works at Genmab A/S, a company known for its innovative approaches to antibody development. Her work has been instrumental in advancing therapeutic options for various diseases.
Collaborations
Throughout her career, Sigrid has collaborated with notable colleagues, including Jessica Teeling and Martin John Glennie. These collaborations have further enhanced her research and contributions to the field.
Conclusion
Sigrid Ruuls is a distinguished inventor whose work in monoclonal antibodies has the potential to impact therapeutic practices significantly. Her innovative research continues to pave the way for advancements in biotechnology.